A stopped phase 3 trial grounded AEterna Zentaris and a downshift in guidance kneecapped Spectrum Pharmaceuticals last week. More
-
-
Sponsored By:
-
Sponsored By:
Biotech
Including this topic: Biotech Movers
1 Stock to Buy, 1 Stock to Short: Biotech
A bullish head-and-shoulders bottom pattern in NPS Pharmaceuticals (NPSP) and a diamond top in United-Guardian (UG) offer two opposite opportunities in biotech. More
Pounce on This Biotech Favorite If it Falls Back Into Buying Range
Celgene Corp. (NASDAQ:CELG) broke from a rectangle consolidation, forming a steep bull channel. More
Bull’s Eye Report: Regeneron Pharmaceuticals (REGN)
Looking for a non-correlated asset to beat the market in a potential downturn? Look no further than biotech stock Regeneron Pharmaceuticals (REGN). More
Biotech Movers: Peregrine, PharmAthene Climb on Analyst Coverage
Last week in biotech news, Peregrine and PharmAthene both climbed on bullish analyst coverage. Also, find out why Sequenom shed double-digits in one day. More
Proprietary Indicator Signals a ‘Buy’ for This Biotech
Qiagen NV (NASDAQ:QGEN) reversed up off of its intermediate bullish support line. More
Biotech Movers: Affymax Crashes on Recall
Last week, shares of Affymax got hammered when the company pulled back units of its sole commercial drug. Plus, find out what sent the biggest gainers skyward. More
